OA OF THE KNEE CAN LIMIT YOUR ABILITY TO PERFORM DAILY ACTIVITIES.
As a result, here are just some of the things you may have a hard time doing:
GETTING THE RIGHT TREATMENT CAN MAKE A BIG DIFFERENCE.
While most people with OA of the knee have some level of disability, it doesn’t mean you can’t get back to your daily routine. Together, you and your doctor can create a treatment plan that fits your lifestyle.
Tell your doctor about all of your symptoms and if your knee OA pain interferes with everyday activities. Also, ask your doctor about treating the signs and symptoms of your knee OA with PENNSAID®. Only you and your doctor can decide if PENNSAID is right for you.
Find out what your treatment options are by reading Getting the right treatment for your knee OA.
Altman RD. Practical considerations for the pharmacologic management of osteoarthritis. Am J Manag Care. 2009;15:S236-S243.
Arthritis Foundation. All about Osteoarthritis. http://www.arthritistoday.org. Accessed January 6, 2011.
Arthritis Foundation. NSAIDs. Arthritis Today Drug Guide. http://www.arthritistoday.org/treatments/drug‑guide/types‑of‑drugs/drug‑guide‑nsaids.php. Accessed January 6, 2011.
Arthritis Foundation. NSAIDs. Who gets osteoarthritis. http://www.arthritis.org/who‑gets‑osteoarthritis.php. Accessed January 6, 2011.
Arthrotec (diclofenac sodium/misoprostol) Tablets USP [prescribing information]. New York, NY: G.D. Searle LLC, Division of Pfizer.
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833-1840.
Diclofenac sodium delayed release tablets USP [prescribing information]. Corona, CA: Watson Laboratories, Inc.
Evans JMM, McMahon AD, McGilchrist MM, et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. Br Med J. 1995;311:22-26.
Heyneman CW, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs. 2000;60:555-574.
Notman R, Noro M, O’Malley B, Anwar J. Molecular basis for dimethylsulfoxide (DMSO) action on lipid membranes. J Am Chem Soc. 2006;128:13982-13983.
PENNSAID [package insert]. Mississauga, Ontario:Nuvo Research, Inc.; 2010.